top of page
  • Writer's pictureNona Kocher

Potential new drug for social anxiety

Updated: Jun 3

A new drug called “fasenediol” has started a phase 3 trial — which means it passed the trials for fewer than 100 patients and is now being rolled out to hundreds to thousands of patients. It has a completely new method of action to combat anxiety — it is to be hoped it will prove to be effective in this phase three trial, and be made available to the public in a few years.

Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2

5 views0 comments

Recent Posts

See All

FDA approves phone app to help with depression

The FDA has approved a phone app called “Rejoyn” to help with depression — Rejoyn incorporates elements of cognitive behavioral therapy, and “emotional faces memory tasks.” Her

New study shows how antidepressants improve brain

A new study shows that antidepressants improve brain function in four ways: Neurons in brains form “networks” — or connections with other neurons across all different regions of the brain. Each netwo


bottom of page